Search Results 341-350 of 19296 for prostate cancer
Giving CJNJ-67652000 and prednisone may kill more tumor cells in patients with metastatic prostate cancer than giving these drugs alone. Participation ...
... prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of ...
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer · Overview · Participation eligibility.
For the study, "Adjuvant Hormonal Therapy Does Not Adversely Impact Overall Survival Following Radical Prostatectomy for Men with High Risk Prostate Cancer When ...
The purpose of this study is to determine the safety of the NanoKnife treatment in prostate cancer tissue when used in a low and intermediate risk patient ...
Willing to provide a tumor tissue sample (archival or recently collected) for determination of HRR gene alterations. Metastatic prostate cancer in the ...
... cancer treatment to between three and five fractions and prostate cancer treatment to five. That shortens the length of treatments from up to two months to ...
The Proteases in Cancer Lab of Evette S. Radisky, Ph.D., at Mayo Clinic is developing mesotrypsin inhibitors for preclinical models of breast cancer, ...
This therapy is an option for some people with neuroendocrine tumors, prostate cancer, meningiomas, thyroid cancer and lymphoma. It has proved to be ...
Prostate cancer experts at Mayo Clinic Comprehensive Cancer Center work in ... cancer, bladder cancer and kidney cancer. Oct. 31, 2014. Bladder cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.